Researchers examined 23 studies, which reported data on 2,896 patients, who were predominantly adult hemodialysis patients. The studies also included data on adult and pediatric oncology patients, critically ill neonates and patients receiving total parenteral nutrition.
The study found that the use of the antimicrobial lock solutions led to a 69 percent reduction in CLABSI rate and a 32 percent reduction in exit-site infections rate as compared to heparin. All-cause mortality was not different between the group that received the lock solutions and the group that didn’t.
More articles on quality:
Hand hygiene education programs: Is once enough?
3rd American missionary contracts Ebola in Liberia
HHS contracts with Mapp on accelerated Ebola treatment development
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.